US EditionAbbVie Inc. (NYSE:ABBV) Given Average Recommendation of “Moderate Buy” by Analysts
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
AbbVie Inc. (NYSE:ABBV) Given Average Recommendation of “Moderate Buy” by Analysts
AbbVie Inc. (NYSE:ABBV – Get Free Report) has earned an average recommendation of “Moderate Buy” from the twenty-seven research firms that are currently covering the company, MarketBeat Ratings reports. Eight equities research analysts have rated the stock with a hold rating, sixteen have given a buy rating and three have assigned a strong buy rating […]
AbbVie Inc. (NYSE:ABBV) Given Average Rating of “Moderate Buy” by Brokerages
Shares of AbbVie Inc. (NYSE:ABBV – Get Free Report) have earned an average rating of “Moderate Buy” from the twenty-seven ratings firms that are currently covering the company, MarketBeat.com reports. Eight research analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and three have issued a strong buy rating […]
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
